A public reimbursement schedule gives a robotics researcher something unusual: a documented amount that can be checked independently of a sales conversation. Its usefulness depends on keeping the question precise. It describes an administrative payment parameter. It does not tell us what every customer pays, what a manufacturer earns, or what the hardware costs to produce.
Start with the observation, then limit the claim
Our medical exoskeleton cost guide reports three rows checked in CMS's January 2026 file. The K1007 schedule amount is $95,081.03. That is a historical schedule observation, not a September supplier quotation or a promise of payment. A researcher should retain the file name, effective period, code, modifiers and jurisdiction next to any extracted number.
CMS publishes the underlying archive, which permits another reader to repeat that extraction. Reproducibility is the useful feature. A published number becomes misleading when the surrounding conditions disappear during summarisation, especially when a search result or comparison card reduces it to a single apparent product price.
Keep four records separate
| Record | Question it can answer | Additional evidence needed |
|---|---|---|
| Fee-schedule row | What amount appears for this code and period? | Applicable quarter, jurisdiction and modifiers |
| Supplier quotation | What is being charged for this offer? | Named configuration, service scope and validity |
| Claim or benefit estimate | What may the payer and patient owe? | Coverage, allowed charge, deductible and other insurance |
| Manufacturer financial report | What revenue and costs were recognised? | Accounting definitions, product mix and timing |
A difference between any two records is a starting point for investigation. It is not automatically a markup, overpayment or error. For example, a quoted package may contain services omitted from a hardware comparison, while a financial report may combine multiple products and payers.
Why the fee is not a compulsory sales price
CMS's published payment method refers to the lower of the actual charge and fee-schedule amount, subject to the relevant rules. Consequently, a schedule is not evidence that suppliers cannot offer a lower charge. Nor can it establish whether price competition occurs across every provider or payer in this market. Our previous article made that unsupported leap; we have removed it.
For purchasing research, request the actual charge and the proposed billing treatment separately. Ask a provider to identify exclusions, fitting visits, training, accessories and repair responsibilities. Then ask the insurer which parts are covered. Keeping those answers in separate columns prevents an administrative allowance from silently replacing a commercial offer.
A conditional estimate is not an invoice
Multiplying a fee by a coinsurance percentage is useful as an explicitly labelled scenario. It still requires assumptions about the allowed amount, assignment, the deductible and additional coverage. Medicare's equipment coverage guidance sets out the basic conditions; a provider and insurer must resolve the details of an individual case.
A useful estimate should show its assumptions alongside the arithmetic. Record which amount was used, whether coverage is confirmed and what remains undecided. If a supplier's charge is lower, recalculate the scenario from the appropriate allowed amount. Do not describe a scenario as a patient's unavoidable bill or assume that all patients face the same out-of-pocket amount.
Company accounts do not reveal the bill of materials
Dividing reported cost of revenue by devices associated with revenue can produce an accounting ratio. Without a breakdown, it cannot isolate purchased components, assembly labour or a bill of materials. The period may also include services, different configurations or costs recognised on a different timetable. Calling the result hardware manufacturing cost overstates the evidence.
A blended average selling price has a similar limitation. Even if it lies between two fee-schedule values, it does not identify the sales mix. That inference would require all relevant transactions to follow the assumed prices and the same recognition rules. Product, payer, geography and service differences need to be examined first. We therefore withdrew the earlier product-mix and pure-hardware-cost estimates instead of relabelling them as established facts.
How to build a defensible comparison
Begin with the decision: a patient budgeting equipment, a hospital comparing systems and a researcher studying reimbursement need different records. Save the original documents, identify which fields support each statement and distinguish direct observations from assumptions. Track later fee files separately so a new amount does not overwrite the historical observation behind an earlier calculation.
Use the medical robot research directory to organise candidate names, then obtain model-specific documents. If a question cannot be answered from the available material, make that gap visible. A narrower conclusion supported by the right record is more useful than a precise number attached to the wrong financial concept.
Correction dated September 16, 2026: this article no longer claims that a fee schedule prevents lower supplier prices or measures hardware manufacturing costs. It is a research framework, not a determination of medical eligibility, coverage or investment value.
